Big Shots

Analysing Divi's Laboratories with Dr Tanmay Motiwala

Created on 01 Mar 2023

Wraps up in 12 Min

Read by 321 people

Updated on 03 Mar 2023

Premium articleElite

Introducing Dr Tanmay Motiwala - a man with a passion for paediatric surgery and a keen eye for the world of investments. When it comes to the world of stocks, Dr Motiwala is no ordinary investor. He combines his medical knowledge and analytical skills to make informed decisions in the market, and one of his top picks is none other than Divi's Laboratories. So, join us as we dive into the world of Divi's Laboratories with Dr Tanmay Motiwala, with his unique approach and expertise.

The pharmaceutical industry involves sourcing raw materials to produce Key Starting Materials (KSM), which are processed to create Active Pharmaceutical Ingredients (APIs). APIs are used to create finished dosage forms like tablets, capsules, and injections that are packaged and distributed to healthcare providers and patients. 

You are missing out on so much.

To continue reading, Subscribe.

You can have unlimited access to all the Elite Articles. Log in to check if your Finology account is ready for Elite.

By Subscribing to Finology One, you can unlock more superpowers -

  • Up to 3 premium articles every week
  • 15+ Stock recommendations with Recipe.
  • 45+ premium courses with Quest.
  • Valuation Calculators and more tools with Ticker.

You get all of these in one, with One.

comment on this article
share this article
Photo of Kirti Pimpalgaonkar

An Article By -

Kirti Pimpalgaonkar

48 Posts


38 Post Likes

The celebrity Youtuber at Finology who is ‘everything at once’, be it knowing financial concepts, making videos & reels, social media marketing, content creation or whatnot. She makes anything and everything her own and delivers the best. Kirti is often called the in-house Pranjal Kamra when it comes to making videos. Finology's very own occasional Zumba teacher whom her colleagues  love & adore.

Topics under this Article

Share your thoughts

We showed you ours, now you show us yours (opinions 😉)

no comments on this article yet

Why not start a conversation?

Looks like nobody has said anything yet. Would you take this as an opportunity to start a discussion or a chat fight may be.

Under Big Shots

"A few" articles ain't enough! Explore more under this category.

Share this post
share on facebook


share on twitter


share on whatsapp


share on linkedin


Or copy the link to this post -

copy url to this post